Freestone Capital Holdings LLC Invests $467,000 in MetLife, Inc. (NYSE:MET)

Freestone Capital Holdings LLC acquired a new position in shares of MetLife, Inc. (NYSE:METFree Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 6,306 shares of the financial services provider’s stock, valued at approximately $467,000.

Several other hedge funds have also made changes to their positions in the business. CreativeOne Wealth LLC boosted its holdings in shares of MetLife by 74.2% during the first quarter. CreativeOne Wealth LLC now owns 5,804 shares of the financial services provider’s stock worth $430,000 after purchasing an additional 2,472 shares during the last quarter. Delap Wealth Advisory LLC acquired a new position in MetLife in the first quarter valued at $206,000. Payden & Rygel Investment Group acquired a new position in MetLife in the first quarter valued at $21,907,000. Ossiam boosted its holdings in MetLife by 363.7% in the first quarter. Ossiam now owns 143,492 shares of the financial services provider’s stock valued at $10,634,000 after acquiring an additional 112,550 shares during the last quarter. Finally, Natixis acquired a new position in MetLife in the first quarter valued at $224,000. Institutional investors and hedge funds own 89.81% of the company’s stock.

MetLife Stock Up 0.9 %

Shares of NYSE:MET traded up $0.68 during trading on Friday, hitting $76.00. The company’s stock had a trading volume of 1,335,162 shares, compared to its average volume of 3,321,235. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a fifty-two week low of $57.91 and a fifty-two week high of $76.90. The stock’s 50-day moving average price is $71.65 and its two-hundred day moving average price is $70.95. The company has a market capitalization of $54.05 billion, a PE ratio of 26.07, a PEG ratio of 0.64 and a beta of 1.11.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.83. MetLife had a return on equity of 20.39% and a net margin of 3.50%. The firm had revenue of $17.02 billion for the quarter, compared to analysts’ expectations of $17.73 billion. During the same quarter in the prior year, the firm posted $1.52 earnings per share. MetLife’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, sell-side analysts expect that MetLife, Inc. will post 8.59 EPS for the current year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 10th. Stockholders of record on Tuesday, August 6th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.87%. The ex-dividend date of this dividend is Tuesday, August 6th. MetLife’s payout ratio is 74.91%.

MetLife announced that its Board of Directors has authorized a share repurchase program on Wednesday, May 1st that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to purchase up to 6% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s management believes its shares are undervalued.

Analyst Upgrades and Downgrades

MET has been the topic of a number of research analyst reports. Citigroup lifted their target price on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a report on Tuesday. Morgan Stanley lifted their target price on MetLife from $82.00 to $83.00 and gave the company an “overweight” rating in a report on Wednesday, July 10th. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a report on Monday, July 1st. Piper Sandler reduced their target price on MetLife from $85.00 to $82.00 and set an “overweight” rating on the stock in a report on Monday, May 6th. Finally, Jefferies Financial Group boosted their price objective on MetLife from $83.00 to $86.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $81.08.

Get Our Latest Stock Report on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.